I have big news! With your help, we CAN cure Angelman syndrome. Thank you for joining our 2021 Cure Angelman Now (CAN) campaign. Together in 2021, we raised $891,519 to support our mission!!!

Research funded by FAST identified a way to turn on a gene that is normally turned off in the brain. FAST took this discovery and started its own biotechnology company to move this technology from the laboratory into human clinical trials. Trials were initiated in 2020 and early preliminary results suggest this therapeutic may effectively treat the symptoms of Angelman syndrome.

I have more exciting news - this approach is just one of the ways FAST is leading the efforts to develop effective treatments for Angelman syndrome. FAST funds multiple programs aimed at developing therapeutics to treat the root cause of Angelman syndrome as well as therapeutics that may treat certain symptoms. In fact, FAST is the largest non-governmental funder of Angelman specific research and relies on grassroots donors like me and you to support these groundbreaking programs.

I look forward to sharing amazing updates and progress with you throughout the year and I thank you for assisting me to Cure Angelman Now.

Please help me reach this goal. Thank you in advance for your generosity.